Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
RX
- Prescription Medicines
CEFALEXINA ARENA 500 mg
First-generation cephalosporin antibiotic, indicated in bacterial infections
Capsules
500 mg
CEFUROXIMA ARENA 250 mg
Second-generation cephalosporin antibiotic, with broad spectrum of action
Capsules
250 mg
CHINIDINA ARENA 200 mg
Antiarrhythmic drug indicated in the treatment of atrial fibrillation and other cardiac rhythm disorders
Tablets
200 mg
CIMETIDINA ARENA 200 mg
Gastric antisecretory drug (H2 antagonist), indicated in the treatment of ulcer and gastroesophageal reflux
Capsules
200 mg
CINARIZINA 25 mg
Antihistamine and cerebral vasodilator, indicated in vertigo and cerebral circulation disorders
Tablets
25 mg
CINARIZINA ARENA 25 mg
Antihistamine and cerebral vasodilator, indicated in vertigo and cerebral circulation disorders
Capsules
25 mg
CIPROFLOXACINA ARENA 100 mg
Fluoroquinolone antibiotic, with broad spectrum, indicated in severe bacterial infections
Film-coated tablets
100 mg
CIPROFLOXACINA ARENA 250 mg
Fluoroquinolone antibiotic, with broad spectrum, indicated in severe bacterial infections
Film-coated tablets
250 mg
CIPROFLOXACINA ARENA 500 mg
Fluoroquinolone antibiotic, with broad spectrum, indicated in severe bacterial infections
Film-coated tablets
500 mg